Human Milk Oligosaccharides (HMOs) Engineered to Mimic Breastmilk
The researchers at Nestle discovered that a specific strain of bifidobacterium, B. infantis LMG11588, efficiently absorbs and metabolizes HMOs. This enhances the strain’s capacity to selectively metabolize HMOs and produce vital beneficial compounds that closely resemble those found in breast milk.